United States · FDA National Drug Code directory
Liothyronine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 39822-0151_02f79412-2198-a8af-e063-6394a90a0853
- Product NDC
- 39822-0151
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Liothyronine Sodium
- Labeler
- XGen Pharmaceuticals DJB, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050817
- Source listing expiry
- 20261231
Source-listed ingredients
- LIOTHYRONINE SODIUM — 10 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL · 39822-0151-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →